Tag: topline results

Pfizer announces positive dermatitis therapy phase III results

by Anna Smith | May 16, 2019 | News | 0

The company’s Janus kinase 1 has met all co-primary and secondary endpoints in a pivotal Phase III study.

Read More

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999